Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) General Counsel Benjamin Landry sold 19,268 shares of the firm's stock in a transaction dated Friday, December 6th. The stock was sold at an average price of $8.32, for a total value of $160,309.76. Following the transaction, the general counsel now directly owns 72,250 shares in the company, valued at approximately $601,120. The trade was a 21.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Health Catalyst Trading Up 0.4 %
Shares of HCAT opened at $8.37 on Wednesday. The stock has a fifty day moving average of $8.13 and a two-hundred day moving average of $7.39. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41. The company has a market capitalization of $509.30 million, a PE ratio of -6.20 and a beta of 1.31. Health Catalyst, Inc. has a fifty-two week low of $5.42 and a fifty-two week high of $11.41.
Health Catalyst (NASDAQ:HCAT - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.03). Health Catalyst had a negative net margin of 26.20% and a negative return on equity of 7.51%. The company had revenue of $76.40 million for the quarter, compared to analysts' expectations of $76.27 million. During the same period in the prior year, the firm earned ($0.22) earnings per share. The firm's quarterly revenue was up 3.5% on a year-over-year basis. As a group, analysts forecast that Health Catalyst, Inc. will post -0.33 EPS for the current year.
Institutional Trading of Health Catalyst
The #1 Crypto for AI
From Weiss Ratings | Ad
We’ve issued an urgent landmark trade alert for a new crypto wonder.
So, I decided to give you this heads-up before it’s too late.
It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”
Learn more about it by watching THIS NOW.
Several institutional investors have recently made changes to their positions in the stock. Primecap Management Co. CA boosted its position in Health Catalyst by 14.7% during the 2nd quarter. Primecap Management Co. CA now owns 2,379,462 shares of the company's stock worth $15,205,000 after purchasing an additional 305,079 shares during the period. Janney Montgomery Scott LLC purchased a new stake in Health Catalyst during the 3rd quarter worth $897,000. Fred Alger Management LLC acquired a new position in Health Catalyst in the 3rd quarter worth $6,858,000. Essex Investment Management Co. LLC acquired a new position in Health Catalyst in the 3rd quarter worth $2,012,000. Finally, Millrace Asset Group Inc. acquired a new position in Health Catalyst in the 3rd quarter worth $1,568,000. 85.00% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research firms recently issued reports on HCAT. Citigroup raised their price target on Health Catalyst from $9.00 to $10.50 and gave the stock a "buy" rating in a report on Wednesday, November 13th. JPMorgan Chase & Co. raised their price target on Health Catalyst from $10.00 to $13.00 and gave the stock an "overweight" rating in a report on Wednesday, September 4th. Evercore ISI raised their price target on Health Catalyst from $8.00 to $10.00 and gave the stock an "outperform" rating in a report on Tuesday, October 8th. Royal Bank of Canada raised their price target on Health Catalyst from $8.00 to $9.00 and gave the stock a "sector perform" rating in a report on Thursday, November 7th. Finally, Piper Sandler reissued an "overweight" rating and set a $12.00 price target (up previously from $11.00) on shares of Health Catalyst in a report on Tuesday, November 26th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $11.79.
Get Our Latest Stock Report on Health Catalyst
About Health Catalyst
(
Get Free Report)
Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
